Targeting p21 for diabetes: Another choice of senotherapy
- PMID: 34986338
- DOI: 10.1016/j.cmet.2021.12.008
Targeting p21 for diabetes: Another choice of senotherapy
Abstract
Senotherapy, the elimination of senescent cells, is a cutting-edge treatment for aging-related and lifestyle diseases. In this issue of Cell Metabolism, Wang et al. report that p21Cip1 highly expressing cells, which represent a senescent cell population, occur in the adipose tissue during obesity. Targeting them genetically or pharmacologically attenuates insulin resistance, suggesting a possible therapeutic approach to treat the metabolic complications of obesity.
Copyright © 2021 Elsevier Inc. All rights reserved.
Comment on
-
Targeting p21Cip1 highly expressing cells in adipose tissue alleviates insulin resistance in obesity.Cell Metab. 2022 Jan 4;34(1):75-89.e8. doi: 10.1016/j.cmet.2021.11.002. Epub 2021 Nov 22. Cell Metab. 2022. PMID: 34813734 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
